A characteristic cerebellar biosignature for bipolar disorder, identified with fully automatic machine learning

Georgios V. Thomaidis; Konstantinos Papadimitriou; Sotirios Michos; Evangelos Chartampilas; Ioannis Tsamardinos

doi:10.1101/2022.01.22.22269384

Abstract

Backround Transcriptomic profile differences between patients with bipolar disorder and healthy controls can be identified using machine learning and can provide information about the potential role of the cerebellum in the pathogenesis of bipolar disorder.With this aim, user-friendly, fully automated machine learning algorithms can achieve extremely high classification scores and disease-related predictive biosignature identification, in short time frames and scaled down to small datasets.

Method A fully automated machine learning platform, based on the most suitable algorithm selection and relevant set of hyper-parameter values, was applied on a preprocessed transcriptomics dataset, in order to produce a model for biosignature selection and to classify subjects into groups of patients and controls. The parent GEO datasets were originally produced from the cerebellar and parietal lobe tissue of deceased bipolar patients and healthy controls, using Affymetrix Human Gene 1.0 ST Array.

Results Patients and controls were classified into two separate groups, with no close-to-the-boundary cases, and this classification was based on the cerebellar transcriptomic biosignature of 25 features (genes), with Area Under Curve 0.929 and Average Precision 0.955. Using 6 of the characteristic features (genes) discovered during the selection process, 99,6% of predictive performance was achieved. The 3 genes contributing most to the predictive power of the model (92,7% predictive performance) are also deregulated in temporal lobe epilepsy. KEGG analysis revealed participation of 4 identified features in 6 pathways which have been associated with bipolar disorder.

Conclusion 93% Area Under Curve, 96% Average Precision, and complete separation between unaffected controls and patients with bipolar disorder, were achieved in ∼2 hours. The cerebellar transcriptomic biosignature suggests a potential genetic overlap with temporal lobe epilepsy and new genetic contributions to the pathogenesis of bipolar disorder.

Competing Interest Statement

Professor Ioannis Tsamardinos is the CEO and Co-founder of Gnosis DA, which has developed JADBIO under his supervision .

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study data are openly available at Gene Expression Omnibus at : https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35978 And at Dataome / Mensxmachina Database at: http://dataome.mensxmachina.org/data/Homo%20sapiens/GPL6244/GSE35977.csv

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

KEGG analysis KEGG Patways New results interpretation Relevant References Reference updates

Data Availability

All data produced in the present study are available upon reasonable request to the authors

https://docs.google.com/document/d/13ehWWGhczwTii47jcTaGUwdJTu8aB3ZjT1D89_mpY3I/edit?usp=sharing

Abbreviation List

AutoML: Automatic Machine Learning
GEO: Gene Expression Omnibus
AUC: Area Under Curve
AP: Average Precision
TLE: Temporal Lobe Epilepsy
BD: Bipolar Disorder
CNS: Central Nervous System
JADBIO: Just Add Data Bio
SES: Statistically Equivalent bioSignatures
LASSO: Least Absolute Shrinkage and Selection Operator
ROC: Receiver Operating Characteristic (curve)
CI: Confidence Interval
UMAP: Uniform Manifold Approximation and Projection

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.